Fatty liver disease and diabetes

Monika Pazgan-Simon

eISSN: 2450-4459
ISSN: 2450-3517

Lekarz POZ

Current issue Archive Manuscripts accepted About the journal Supplements Abstracting and indexing Subscription Contact Instructions for authors

Editorial System

Submit your Manuscript

4/2018
vol. 4

Send email

Copy url:

abstract:

Review paper

Fatty liver disease and diabetes

Monika Pazgan-Simon

Online publish date: 2018/10/15

View full text Get citation

Nonalcoholic steatohepatitis is one of the most common hepatologic diagnoses. About 30% adults

have NAFLD in developed countries. Diabetes and metabolic syndrome often coexist with NAFLD. Among patients we observe a natural history of this disease: hepatosteatosis (NAFL), steatohepatitis (NASH) with and without fibrosis, liver cirrhosis,

and hepatocellular carcinoma. Diagnostics tools are USG of the liver, biochemical tests: triglyceride level, ALT, and AST. There are dietic treatments and some physical exercise, with final weight loss, then some drugs like metformin, statins, or bariatric surgery.

keywords:

Fatty liver disease and diabetes

Monika Pazgan-Simon

liver steatosis, nonalcoholic steatohepatitis, diabetes